Page last updated: 2024-08-16

trimethobenzamide and apomorphine

trimethobenzamide has been researched along with apomorphine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ahlskog, JE; Dewey, RB; Maraganore, DM; Matsumoto, JY2
JUSTIN-BESANCON, L; LAVILLE, C1
Dewey, RB1
Clinch, T; Hauser, RA; Isaacson, S1

Reviews

1 review(s) available for trimethobenzamide and apomorphine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

3 trial(s) available for trimethobenzamide and apomorphine

ArticleYear
Intranasal apomorphine rescue therapy for parkinsonian "off" periods.
    Clinical neuropharmacology, 1996, Volume: 19, Issue:3

    Topics: Administration, Intranasal; Antiemetics; Antiparkinson Agents; Apomorphine; Benzamides; Carbidopa; Dopamine Agonists; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting

1996
A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:5

    Topics: Administration, Intranasal; Aerosols; Aged; Antiemetics; Antiparkinson Agents; Apomorphine; Benzamides; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pilot Projects; Premedication; Treatment Outcome

1998
Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection.
    Parkinsonism & related disorders, 2014, Volume: 20, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antiemetics; Apomorphine; Benzamides; Dopamine Agonists; Double-Blind Method; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Male; Middle Aged; Nausea; Parkinson Disease; Severity of Illness Index; Time Factors; Vomiting; Young Adult

2014

Other Studies

2 other study(ies) available for trimethobenzamide and apomorphine

ArticleYear
[ANTIEMETIC ACTION OF METOCLOPRAMIDE WITH RESPECT TO APOMORPHINE AND HYDERGINE].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1964, Volume: 158

    Topics: Antiemetics; Apomorphine; Benzamides; Cardiovascular Agents; Chlorpromazine; Dihydroergotoxine; Diphenhydramine; Dogs; Ergoloid Mesylates; Ergot Alkaloids; Metoclopramide; Oxytocics; Pharmacology; Prochlorperazine; Research; Toxicology

1964
10 questions about using apomorphine for Parkinson disease.
    The neurologist, 2005, Volume: 11, Issue:3

    Topics: Antiemetics; Antiparkinson Agents; Apomorphine; Benzamides; Humans; Injections, Intravenous; Parkinson Disease; Recurrence; Vomiting

2005